Follow the 奥美医疗 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 奥美医疗 has recorded 3 reports. Market capitalisation: €5.8bn. The latest transaction was reported on 8 December 2022 (Sale). Among the most active insiders: 裴春梅. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
奥美医疗 is a company focused on the healthcare and pharmaceutical sector, providing medical products and services. It is listed on the XSHE market.